Cytek Biosciences, Inc. (CTKB)

6.27 -0.11 (-1.72%) At close: 04:00PM EDT

Cytek Biosciences, Inc.

47215 Lakeview Boulevard
Fremont, CA 94538
United States
877 922 9835
https://cytekbio.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 676

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Wenbin Jiang Ph.D.	President, CEO & Chairman of the Board	939.24k	N/A	1964
Dr. Ming Yan Ph.D.	CTO & Director	570.12k	N/A	1963
Ms. Valerie T. Barnett J.D.	Chief Legal Officer & Corporate Secretary	612.39k	N/A	1975
Dr. Allen B. Poirson Ph.D.	Senior Vice President of Business & Corporate Development	576.28k	N/A	1960
Mr. Patrik Sebastian Jeanmonod	Head of Corporate Development Analytics	536.09k	N/A	1967
Mr. William D. McCombe	Chief Financial Officer	N/A	N/A	1958
Mr. Chris Williams	Chief Operating Officer	N/A	N/A	1969
Dr. Philippe Busque Ph.D.	Senior Vice President of Global Sales & Services	N/A	N/A	1971

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Corporate Governance

Cytek Biosciences, Inc.’s ISS Governance QualityScore as of May 1, 2024 is 9. The pillar scores are Audit: 10; Board: 7; Shareholder Rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.